Hong WK - Search Results

1

Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.

Chang YS, Wang L, Suh YA, Mao L, Karpen SJ, Khuri FR, Hong WK, Lee HY. Chang YS, et al. Among authors: hong wk. Oncogene. 2004 Aug 26;23(39):6569-80. doi: 10.1038/sj.onc.1207882. Oncogene. 2004. PMID: 15247904

2

Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

Kim WY, Kim MJ, Moon H, Yuan P, Kim JS, Woo JK, Zhang G, Suh YA, Feng L, Behrens C, Van Pelt CS, Kang H, Lee JJ, Hong WK, Wistuba II, Lee HY. Kim WY, et al. Among authors: hong wk. Endocrinology. 2011 Jun;152(6):2164-73. doi: 10.1210/en.2010-0693. Epub 2011 Mar 29. Endocrinology. 2011. PMID: 21447628 Free PMC article.

3

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR. Lu C, et al. Among authors: hong wk. J Clin Oncol. 2004 Nov 15;22(22):4575-83. doi: 10.1200/JCO.2004.01.091. J Clin Oncol. 2004. PMID: 15542809

4

Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma.

Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY. Oh SH, et al. Among authors: hong wk. Clin Cancer Res. 2006 Jan 15;12(2):653-61. doi: 10.1158/1078-0432.CCR-05-1725. Clin Cancer Res. 2006. PMID: 16428512

5

Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.

Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM. Lee HY, et al. Among authors: hong wk. Cancer Res. 2002 Jun 15;62(12):3530-7. Cancer Res. 2002. PMID: 12068000

6

Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.

Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY. Chang YS, et al. Among authors: hong wk. Clin Cancer Res. 2002 Dec;8(12):3669-75. Clin Cancer Res. 2002. PMID: 12473575

7

Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.

Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY. Chang YS, et al. Among authors: hong wk. Clin Cancer Res. 2002 Dec;8(12):3796-802. Clin Cancer Res. 2002. PMID: 12473592

8

Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.

Chang YS, Wu W, Walsh G, Hong WK, Mao L. Chang YS, et al. Among authors: hong wk. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3641-4. Clin Cancer Res. 2003. PMID: 14506152

9

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.

Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L. Ren H, et al. Among authors: hong wk. J Clin Oncol. 2004 Aug 15;22(16):3230-7. doi: 10.1200/JCO.2004.02.080. J Clin Oncol. 2004. PMID: 15310766

10

Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.

Wang J, Lee JJ, Wang L, Liu DD, Lu C, Fan YH, Hong WK, Mao L. Wang J, et al. Among authors: hong wk. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6119-25. doi: 10.1158/1078-0432.CCR-04-0652. Clin Cancer Res. 2004. PMID: 15447998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

761 results

Search Page

Filters